共 91 条
[1]
Reinehr T(2018)Vanishing 17-hydroxyprogesterone concentrations in 21-hydroxylase deficiency Horm Res Paediatr 90 138-144
[2]
Rothermel J(2010)Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening Clin Chim Acta 411 1684-1687
[3]
Wegener-Panzer A(2018)Basal levels of 17-hydroxyprogesterone can distinguish children with isolated precocious pubarche Pediatr Res 84 533-536
[4]
Hartmann MF(2019)Newborn screening for congenital adrenal hyperplasia: beyond 17-hydroxyprogesterone concentrations J Pediatr 95 257-259
[5]
Wudy SA(2014)Polycystic ovary syndrome: update on diagnosis and treatment Am J Med 127 912-919
[6]
Holterhus PM(2002)Limitations of steroid determination by direct immunoassay Clin Chem 48 583-585
[7]
De Jesus VR(2004)Improving neonatal screening for congenital adrenal hyperplasia J Clin Endocrinol Metab 89 3685-3686
[8]
Simms DA(2009)False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17α-hydroxyprogesterone (17-OHP) values Steroids. 74 662-665
[9]
Schiffer J(2005)Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency Clin Chem 51 298-304
[10]
Kennedy M(2016)Evaluation of an isotope dilution HPLC tandem mass spectrometry candidate reference measurement procedure for total 17-β estradiol in human serum Anal Chem 88 11123-11129